BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36217736)

  • 1. Midterm Durability and Structural Valve Degeneration of Transcatheter Aortic Valve Replacement in a Federal Facility.
    Yang R; Grober AF; Riojas R; Ponna V; Shunk KA; Zimmet JM; Gustafson J; Ge L; Tseng EE
    Innovations (Phila); 2022 Sep; 17(5):382-391. PubMed ID: 36217736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
    Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
    J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement.
    de Freitas Campos Guimarães L; Urena M; Wijeysundera HC; Munoz-Garcia A; Serra V; Benitez LM; Auffret V; Cheema AN; Amat-Santos IJ; Fisher Q; Himbert D; Garcia Del Blanco B; Dager A; Le Breton H; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007038. PubMed ID: 30354588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on durability and structural valve deterioration in TAVR and surgical AVR.
    Okutucu S; Niazi AK; Oliveira D; Fatihoglu SG; Oto A
    Acta Cardiol; 2021 Nov; 76(9):921-932. PubMed ID: 33302806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Durability of Transcatheter Aortic Valve Prostheses.
    Blackman DJ; Saraf S; MacCarthy PA; Myat A; Anderson SG; Malkin CJ; Cunnington MS; Somers K; Brennan P; Manoharan G; Parker J; Aldalati O; Brecker SJ; Dowling C; Hoole SP; Dorman S; Mullen M; Kennon S; Jerrum M; Chandrala P; Roberts DH; Tay J; Doshi SN; Ludman PF; Fairbairn TA; Crowe J; Levy RD; Banning AP; Ruparelia N; Spence MS; Hildick-Smith D
    J Am Coll Cardiol; 2019 Feb; 73(5):537-545. PubMed ID: 30732706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis.
    Werner P; Coti I; Kaider A; Gritsch J; Mach M; Kocher A; Laufer G; Andreas M
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):416-424. PubMed ID: 34738111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after transcatheter aortic valve replacement: Meta-analysis of Kaplan-Meier-derived data.
    Shimamura J; Takemoto S; Fukuhara S; Miyamoto Y; Yokoyama Y; Takagi H; Kampaktsis PN; Kolte D; Grubb KJ; Kuno T; Latib A
    Catheter Cardiovasc Interv; 2023 Dec; 102(7):1291-1300. PubMed ID: 37890015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Predictors of Structural Valve Deterioration after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Long YX; Liu ZZ
    J Interv Cardiol; 2020; 2020():4075792. PubMed ID: 33214775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
    Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
    J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
    Dauerman HL; Deeb GM; O'Hair DP; Waksman R; Yakubov SJ; Kleiman NS; Chetcuti SJ; Hermiller JB; Bajwa T; Khabbaz K; de Marchena E; Salerno T; Dries-Devlin JL; Li S; Popma JJ; Reardon MJ
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008155. PubMed ID: 31607151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography predictors of structural valve degeneration in patients undergoing transcatheter aortic valve implantation with balloon-expandable prostheses.
    Guglielmo M; Fusini L; Muratori M; Tamborini G; Mantegazza V; Andreini D; Annoni A; Babbaro M; Baggiano A; Conte E; Carriero S; Formenti A; Guaricci AI; Mancini E; Mollace R; Muscogiuri G; Mushtaq S; Ricci F; Rossi A; Scafuri S; Alushi B; Cau C; Cau R; Cesarano M; Saba L; Rabbat M; Pepi M; Pontone G
    Eur Radiol; 2022 Sep; 32(9):6017-6027. PubMed ID: 35364711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Sathananthan J; Lauck S; Polderman J; Yu M; Stephenson A; Sathananthan G; Moss R; Cheung A; Ye J; Blanke P; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):E431-E437. PubMed ID: 32940418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Didier R; Eltchaninoff H; Donzeau-Gouge P; Chevreul K; Fajadet J; Leprince P; Leguerrier A; Lièvre M; Prat A; Teiger E; Lefevre T; Tchetché D; Carrié D; Himbert D; Albat B; Cribier A; Sudre A; Blanchard D; Rioufol G; Collet F; Houel R; Dos Santos P; Meneveau N; Ghostine S; Manigold T; Guyon P; Cuisset T; Le Breton H; Delepine S; Favereau X; Souteyrand G; Ohlmann P; Doisy V; Lognoné T; Gommeaux A; Claudel JP; Bourlon F; Bertrand B; Iung B; Gilard M
    Circulation; 2018 Dec; 138(23):2597-2607. PubMed ID: 30571260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk.
    O'Hair D; Yakubov SJ; Grubb KJ; Oh JK; Ito S; Deeb GM; Van Mieghem NM; Adams DH; Bajwa T; Kleiman NS; Chetcuti S; Søndergaard L; Gada H; Mumtaz M; Heiser J; Merhi WM; Petrossian G; Robinson N; Tang GHL; Rovin JD; Little SH; Jain R; Verdoliva S; Hanson T; Li S; Popma JJ; Reardon MJ
    JAMA Cardiol; 2023 Feb; 8(2):111-119. PubMed ID: 36515976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Jang MH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Lee SA; Kim DH; Kim H; Choi Y; Lee J; Park SJ; Park DW
    Heart; 2023 Dec; 110(2):140-147. PubMed ID: 37586823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review.
    Gallo M; Fovino LN; Blitzer D; Doulamis IP; Guariento A; Salvador L; Tagliari AP; Ferrari E
    Eur J Cardiothorac Surg; 2022 May; 61(5):967-976. PubMed ID: 34662376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: An Updated Meta-Analysis.
    Sá MPBO; Van den Eynde J; Simonato M; Cavalcanti LRP; Doulamis IP; Weixler V; Kampaktsis PN; Gallo M; Laforgia PL; Zhigalov K; Ruhparwar A; Weymann A; Pibarot P; Clavel MA
    JACC Cardiovasc Interv; 2021 Jan; 14(2):211-220. PubMed ID: 33478639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.